Nanotransfection-based vasculogenic cell reprogramming drives functional recovery in a mouse model of ischemic stroke

Ischemic stroke causes vascular and neuronal tissue deficiencies that could lead to substantial functional impairment and/or death. Although progenitor-based vasculogenic cell therapies have shown promise as a potential rescue strategy following ischemic stroke, current approaches face major hurdles...

Descripción completa

Detalles Bibliográficos
Autores principales: Lemmerman, Luke R., Balch, Maria H. H., Moore, Jordan T., Alzate-Correa, Diego, Rincon-Benavides, Maria A., Salazar-Puerta, Ana, Gnyawali, Surya, Harris, Hallie N., Lawrence, William, Ortega-Pineda, Lilibeth, Wilch, Lauren, Risser, Ian B., Maxwell, Aidan J., Duarte-Sanmiguel, Silvia, Dodd, Daniel, Guio-Vega, Gina P., McTigue, Dana M., Arnold, W. David, Nimjee, Shahid M., Sen, Chandan K., Khanna, Savita, Rink, Cameron, Higuita-Castro, Natalia, Gallego-Perez, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978431/
https://www.ncbi.nlm.nih.gov/pubmed/33741587
http://dx.doi.org/10.1126/sciadv.abd4735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978431/
https://www.ncbi.nlm.nih.gov/pubmed/33741587
http://dx.doi.org/10.1126/sciadv.abd4735

Ejemplares similares